实用肿瘤学杂志 ›› 2012, Vol. 26 ›› Issue (4): 381-384.doi: 10.3969/j.issn.1002-3070.2012.04.022

• 综述 • 上一篇    

c-kit在小细胞肺癌中的研究进展

李娜, 洪璇, 陈公琰   

  1. 哈尔滨医科大学附属肿瘤医院内一科(哈尔滨 150081)
  • 收稿日期:2011-11-17 出版日期:2012-08-28 发布日期:2014-12-03
  • 通讯作者: 陈公琰,E-mail:chengongyan@medmail.com.cn
  • 作者简介:李娜,女,(1985-),硕士研究生,从事肺癌的内科治疗及靶向治疗

Progress of c-kit in small cell lung cancer

LI Na,HONG Xuan,CHEN Gongyan   

  1. Department of Internal Medicine,The Third Affiliated Hospital of Harbin Medical University,Harbin 150081
  • Received:2011-11-17 Online:2012-08-28 Published:2014-12-03

摘要: 小细胞肺癌约占全部肺癌的15%~20%,其因复杂的病理生理学特征和高度恶性引起了医学界的广泛关注。c-kit受体属于III型酪氨酸激酶受体家族,对某些正常细胞的分化、增殖、发育及功能维持起重要作用。近来研究发现小细胞肺癌组织有c-kit受体的异常表达,c-kit基因的突变,由此推测c-kit受体的异常表达及突变与小细胞肺癌的发生存在一定的关系。本文阐述了c-kit在小细胞肺癌中的研究进展。

Abstract: Small-cell lung cancer(SCLC)accounts for 15%~20% of all lung cancer worldwide.Many medical scientists pay more attention to it,due to its pathophysiology feature and high malignancy.The c-kit protein is a member of the type III receptor tyrosine kinase family.It promotes some normal cells differentiation,proliferation,and maintain cell function.Recent studies found that the expression and mutation of c-kit exist in small cell lung cancer samples.People presume that the mechanism of SCLC is relation to expression and mutation of c-kit.This article demonstrate the progression of c-kit receptor in SCLC.

中图分类号: